A detailed history of Linden Thomas Advisory Services, LLC transactions in Xencor Inc stock. As of the latest transaction made, Linden Thomas Advisory Services, LLC holds 43,643 shares of XNCR stock, worth $864,567. This represents 0.13% of its overall portfolio holdings.

Number of Shares
43,643
Previous 42,944 1.63%
Holding current value
$864,567
Previous $950 Million 13.07%
% of portfolio
0.13%
Previous 0.15%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

BUY
$18.21 - $24.5 $12,728 - $17,125
699 Added 1.63%
43,643 $826 Million
Q1 2024

Apr 29, 2024

BUY
$18.65 - $26.52 $24,077 - $34,237
1,291 Added 3.1%
42,944 $950 Million
Q4 2023

Feb 01, 2024

SELL
$16.53 - $21.42 $17,141 - $22,212
-1,037 Reduced 2.43%
41,653 $884 Million
Q3 2023

Oct 20, 2023

SELL
$20.08 - $25.39 $3,513 - $4,443
-175 Reduced 0.41%
42,690 $860 Million
Q2 2023

Jul 27, 2023

BUY
$24.77 - $29.9 $1.06 Million - $1.28 Million
42,865 New
42,865 $1.07 Billion

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.18B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Linden Thomas Advisory Services, LLC Portfolio

Follow Linden Thomas Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Linden Thomas Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Linden Thomas Advisory Services, LLC with notifications on news.